Stock listing
Bioxcel Therapeutics, Inc.
Selected listing: BX20 · SWB · EUR · DE
Bioxcel Therapeutics, Inc. (Stuttgart:BX20), Health Technology. Latest release May 28, 2026: BioXcel Therapeutics Presents New Data from SERENITY At-Home…
- Ticker
- Stuttgart:BX20
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
About Bioxcel Therapeutics, Inc.
The company focuses on developing innovative therapies to address unmet medical needs. Bioxcel is committed to advancing its pipeline and enhancing patient care through its research and development efforts.
Latest news from Bioxcel Therapeutics, Inc.
BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting
May 28, 2026
BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 15, 2026
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
April 17, 2026
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
April 7, 2026
BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting
March 31, 2026
Events
Research Bioxcel Therapeutics, Inc.
Bioxcel Therapeutics, Inc. company profile
View the public company page for Bioxcel Therapeutics, Inc. on 6ix.
Bioxcel Therapeutics, Inc. news
Read company news and market updates connected to Bioxcel Therapeutics, Inc..
Bioxcel Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Bioxcel Therapeutics, Inc..
Alternate listings
BTAI:NASDAQ
US · USD
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
BTAI:BOATS
US · USD
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
A40YSR:LSX
DE · EUR
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
BX20:GETTEX
DE · EUR
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
A40YSR:LS
DE · EUR
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
BX20:TRADEGATE
DE · EUR
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
BX20:DUS
DE · EUR
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
BX20:FWB
DE · EUR
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
BX20:HAM
DE · EUR
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.
BX20:MUN
DE · EUR
Alternate listing for Bioxcel Therapeutics, Inc.; the primary context on this page is BX20:SWB.